Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

Status:
Terminated

Trial end date:
2010-09-01

Target enrollment:

Participant gender:

This study will assess the safety and efficacy of QAV680 in patients with mild to moderate asthma

Phase 2

Novartis Pharmaceuticals